<?xml version="1.0" encoding="UTF-8"?>
<p>More than half of the acute and convalescent cases (107/208; 51.4%) analyzed in AP were confirmed by molecular and/or serological methodologies. The combined use of serological and molecular tests in the acute phase diagnosis of CHIKV infection may be recommended, since previous studies have demonstrated that anti-CHIKV IgM antibodies can be detected from two days of disease [
 <xref rid="B24-viruses-10-00623" ref-type="bibr">24</xref>,
 <xref rid="B25-viruses-10-00623" ref-type="bibr">25</xref>].
</p>
